Abstract
A young woman presenting with recurrent episodes of uterine bleeding due to an extensive uterine arteriovenous malformation was treated with two sessions of uterine artery embolization. Further bleeding was managed with a combination of gonadotropin-releasing hormone and depot medroxyprogesterone acetate. The patient remains asymptomatic with a significant decrease in uterine and pelvic vascularity at one year follow-up.
These drugs may decrease the need for repeat embolization.
Keywords: Arteriovenous malformation, uterine artery embolization, gonadotropin-releasing hormone agonist, depot medroxyprogesterone acetate
How to Cite:
Krishnaswamy, P., Subbanna, I., Sivasambu, G. & Thukral, U., (2014) “Gonadotropin-releasing hormone agonist and depot medroxyprogesterone acetate following uterine artery embolization in the management of uterine arteriovenous malformation”, Proceedings in Obstetrics and Gynecology 4(1), 1–12. doi: https://doi.org/10.17077/2154-4751.1203
Rights: Copyright © 2014 Padma Krishnaswamy, Indushekar Subbanna, Gayatri Devi Sivasambu, and Urvashi Thukral
Downloads:
Download pdf
View PDF
481 Views
493 Downloads